BioPharmSignal logoBioPharmSignal

Biotech News

Pulse Biosciences to Present at Stifel 2026 Healthcare Conference

Pulse Biosciences (PLSE)Pulse BiosciencesConference / presentation

HAYWARD, Calif. --(BUSINESS WIRE)--Oct. 29, 2026-- Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to participate in the upcoming Stifel 2026 Healthcare

Related news

PLSEPulse Biosciences2026-10-08 11:00 EST

Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026

TMCITreace Medical Concepts2026-11-03 21:05 EST

Treace to Present at the Stifel 2026 Healthcare Conference

ICUIICU Medical2026-11-06 13:30 EST

ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London

IARTIntegra LifeSciences2026-11-06 13:00 EST

Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference

OMOutset Medical2026-10-27 20:05 EST

Outset Medical to Participate in the 2026 Stifel Healthcare Conference

BSXBoston Scientific2026-10-26 12:00 EST

Boston Scientific to participate in Stifel's 2026 Healthcare Conference

ACHCAcadia Healthcare2026-11-02 21:30 EST

Acadia Healthcare to Participate in November Investor Conferences

IRMDiRadimed2026-09-23 13:00 EST

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

ACHCAcadia Healthcare2026-09-09 13:00 EST

Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference

PLSEPulse Biosciences2026-11-06 12:00 EST

Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting

View all latest news

Pulse Biosciences

Nanosecond Pulsed-Field Ablation Pulse Biosciences develops the nPulse platform, which delivers proprietary nanosecond pulsed-field energy to ablate targeted tissue. The technology is designed to create nonthermal cellular effects and is being evaluated in cardiac and soft-tissue applications. Cardiac Catheter System The nPulse Cardiac...

Recent company news

PLSEPulse Biosciences2026-11-06 12:00 EST

Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting

PLSEPulse Biosciences2026-11-05 21:05 EST

Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results

PLSEPulse Biosciences2026-10-29 17:05 EST

Pulse Biosciences to Present at Stifel 2026 Healthcare Conference

PLSEPulse Biosciences2026-10-22 20:05 EST

Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026

PLSEPulse Biosciences2026-10-14 11:00 EST

Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center

Stock data

Close
53.07 USD
Market cap
1.68B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States